Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study
Background: Increased risk of new-onset atrial fibrillation (AF) after patent foramen ovale (PFO) closure was observed in randomized trials without however systematic AF screening. We aimed to evaluate the incidence of AF within 6-month following PFO closure with serial 24-hour ambulatory electrocar...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/caacee63836941cdb5f9a2b5f281adf0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:caacee63836941cdb5f9a2b5f281adf0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:caacee63836941cdb5f9a2b5f281adf02021-11-22T04:27:19ZAtrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study2352-906710.1016/j.ijcha.2021.100919https://doaj.org/article/caacee63836941cdb5f9a2b5f281adf02021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352906721002074https://doaj.org/toc/2352-9067Background: Increased risk of new-onset atrial fibrillation (AF) after patent foramen ovale (PFO) closure was observed in randomized trials without however systematic AF screening. We aimed to evaluate the incidence of AF within 6-month following PFO closure with serial 24-hour ambulatory electrocardiogram (AECG) monitoring. Methods: All patients undergoing PFO closure were prospectively included in 2 centers. AF was defined as irregular rhythm without discernible P waves > 30 s on AECG at day 0, 1-month and 6-month follow-up. Primary endpoint was the incidence of AF within the study period. Secondary endpoints evaluated clinical outcomes within 6-month follow-up. Results: Between February 2018 and March 2019, 62 patients underwent PFO closure including 40 male (64.5%) with a mean age of 48 ± 9.5. Atrial septal aneurysm was observed in 37 patients (64.9%), 57 patients (91.9%) received an Amplatzer Occluder device (Abbott Vascular) and 5 (8.1%) an Occlutech device (Occlutech). After a mean follow-up of 7.7 ± 2.8 months, new-onset AF occurred in 3 patients (4.8%), all within the first month following PFO closure, including one per-procedural, all were asymptomatic and paroxysmal. Two patients with AF (3.2%) required chronic oral anticoagulant therapy. No adverse outcomes occurred at follow-up. No predictive factors of AF were highlighted. A total of 16 patients (25.8%) reported palpitations without AF on the AECGs. Conclusion: In highly selected patients, incidence of AF, evaluated with 3 systematic 24-hour AECG within 6-month following PFO closure, was low (<5%). Always paroxysmal, AF occurred within the first month after the procedure and was not associated with adverse outcomes.Florence LeclercqXavier OdoricoGregory MarinJean Christophe MaciaDelphine DelsenyAudrey AgulloLaurence PagesPierre RobertBenoit LattucaGuillaume CaylaFrançois RoubilleNicolas GaillardCaroline ArquizanMariama AkodadElsevierarticleAtrial FibrillationHolter MonitoringPatent foramen ovalePercutaneous closureDiseases of the circulatory (Cardiovascular) systemRC666-701ENInternational Journal of Cardiology: Heart & Vasculature, Vol 37, Iss , Pp 100919- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Atrial Fibrillation Holter Monitoring Patent foramen ovale Percutaneous closure Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Atrial Fibrillation Holter Monitoring Patent foramen ovale Percutaneous closure Diseases of the circulatory (Cardiovascular) system RC666-701 Florence Leclercq Xavier Odorico Gregory Marin Jean Christophe Macia Delphine Delseny Audrey Agullo Laurence Pages Pierre Robert Benoit Lattuca Guillaume Cayla François Roubille Nicolas Gaillard Caroline Arquizan Mariama Akodad Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study |
description |
Background: Increased risk of new-onset atrial fibrillation (AF) after patent foramen ovale (PFO) closure was observed in randomized trials without however systematic AF screening. We aimed to evaluate the incidence of AF within 6-month following PFO closure with serial 24-hour ambulatory electrocardiogram (AECG) monitoring. Methods: All patients undergoing PFO closure were prospectively included in 2 centers. AF was defined as irregular rhythm without discernible P waves > 30 s on AECG at day 0, 1-month and 6-month follow-up. Primary endpoint was the incidence of AF within the study period. Secondary endpoints evaluated clinical outcomes within 6-month follow-up. Results: Between February 2018 and March 2019, 62 patients underwent PFO closure including 40 male (64.5%) with a mean age of 48 ± 9.5. Atrial septal aneurysm was observed in 37 patients (64.9%), 57 patients (91.9%) received an Amplatzer Occluder device (Abbott Vascular) and 5 (8.1%) an Occlutech device (Occlutech). After a mean follow-up of 7.7 ± 2.8 months, new-onset AF occurred in 3 patients (4.8%), all within the first month following PFO closure, including one per-procedural, all were asymptomatic and paroxysmal. Two patients with AF (3.2%) required chronic oral anticoagulant therapy. No adverse outcomes occurred at follow-up. No predictive factors of AF were highlighted. A total of 16 patients (25.8%) reported palpitations without AF on the AECGs. Conclusion: In highly selected patients, incidence of AF, evaluated with 3 systematic 24-hour AECG within 6-month following PFO closure, was low (<5%). Always paroxysmal, AF occurred within the first month after the procedure and was not associated with adverse outcomes. |
format |
article |
author |
Florence Leclercq Xavier Odorico Gregory Marin Jean Christophe Macia Delphine Delseny Audrey Agullo Laurence Pages Pierre Robert Benoit Lattuca Guillaume Cayla François Roubille Nicolas Gaillard Caroline Arquizan Mariama Akodad |
author_facet |
Florence Leclercq Xavier Odorico Gregory Marin Jean Christophe Macia Delphine Delseny Audrey Agullo Laurence Pages Pierre Robert Benoit Lattuca Guillaume Cayla François Roubille Nicolas Gaillard Caroline Arquizan Mariama Akodad |
author_sort |
Florence Leclercq |
title |
Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study |
title_short |
Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study |
title_full |
Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study |
title_fullStr |
Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study |
title_full_unstemmed |
Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study |
title_sort |
atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: a prospective study |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/caacee63836941cdb5f9a2b5f281adf0 |
work_keys_str_mv |
AT florenceleclercq atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT xavierodorico atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT gregorymarin atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT jeanchristophemacia atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT delphinedelseny atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT audreyagullo atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT laurencepages atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT pierrerobert atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT benoitlattuca atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT guillaumecayla atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT francoisroubille atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT nicolasgaillard atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT carolinearquizan atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy AT mariamaakodad atrialfibrillationscreeningonsystematicambulatoryelectrocardiogrammonitoringafterpercutaneouspatentforamenovaleclosureaprospectivestudy |
_version_ |
1718418186818289664 |